Thomas Catinazzo has not been actively trading shares of Relay Therapeutics during the last ninety days. Most recently, Thomas Catinazzo sold 10,780 shares of the business's stock in a transaction on Monday, July 29th. The shares were sold at an average price of $8.56, for a transaction totalling $92,276.80. Following the completion of the sale, the chief financial officer now directly owns 319,650 shares of the company's stock, valued at $2,736,204. Learn More on Thomas Catinazzo's trading history.